• Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Adriana DN, Miftahussurur M. Current strategy to combat COVID-19 in Indonesia. New Armen Med J. 2020;14:16–28.


    Google Scholar
     

  • Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–7.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Wan Y, Li J, Shen L, Zou Y, Hou L, Zhu L, et al. Enteric involvement in hospitalized patients with COVID-19 outside Wuhan. Lancet Gastroenterol Hepatol. 2020;5:534–5.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467–74.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Gu Y, Wang D, Chen C, Lu W, Liu H, Lv T, et al. PaO2 /FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients. Sci Rep. 2021;11:7334.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115:766–73.

    PubMed 
    Article 

    Google Scholar
     

  • Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical, and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002–9.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Dahiya DS, Kichloo A, Albosta M, Pagad S, Wani F. Gastrointestinal implications in COVID-19. J Investig Med. 2020;68:1397–401.

    PubMed 
    Article 

    Google Scholar
     

  • Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. 2020;65:1932–9.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Beeching NJ, Fletcher TE, Fowler R. BMJ best practice coronavirus disease 2019 (COVID-19). London: BMJ Publishing Group Ltd; 2021. p. 1–364.


    Google Scholar
     

  • Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal–oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021;18:269–83.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, et al. The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications. Inflamm Bowel Dis. 2020;26:1306–14.

    PubMed 
    Article 

    Google Scholar
     

  • Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Trottein F, Sokol H. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 2020;32: 107915.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Jena A, Kumar-M P, Singh AK, Sharma V. Fecal calprotectin levels in COVID-19: lessons from a systematic review on its use in inflammatory bowel disease during the pandemic. Dig Liver Dis. 2021;53:295–7.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, et al. Clinical features and pathogenic mechanisms of gastrointestinal injury in COVID-19. J Clin Med. 2020;9:3630.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010–8.

    CAS 
    Article 

    Google Scholar
     

  • Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol-Gastroint Liver Physiol. 2020;319:245–52.

    Article 
    CAS 

    Google Scholar
     

  • Ma C, Cong Y, Zhang H. COVID-19 and the digestive system. Am J Gastroenterol. 2020;115:1003–6.

    PubMed 
    Article 

    Google Scholar
     

  • Giuffrè M, di Bella S, Sambataro G, Zerbato V, Cavallaro M, Occhipinti AA, et al. COVID-19-induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: hypothesis regarding mechanism of intestinal damage associated with COVID-19. Trop Med Infect Dis. 2020;5:1–5.


    Google Scholar
     

  • Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8:49.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Acheson DWK, Luccioli S. Microbial-gut interactions in health and disease. Mucosal immune responses. Best Pract Res Clin Gastroenterol. 2004;8:387–404.

    Article 
    CAS 

    Google Scholar
     

  • Mago S, Vaziri H, Tadros M. The usefulness of fecal calprotectin in the era of the COVID-19 pandemic. Gastroenterology. 2021;160:2622–3.

    Article 
    CAS 

    Google Scholar
     

  • Burri E, Beglinger C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:197–210.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Bjarnason I. The use of fecal calprotectin in inflammatory bowel disease. Gastroenterol Hepatol. 2017;13:53–6.


    Google Scholar
     

  • Giuffrè M, Vetrugno L, di Bella S, Moretti R, Berretti D, Crocè LS. Calprotectin and SARS-CoV-2: a brief-report of the current literature. Healthcare (Switzerland). 2021;9:956.


    Google Scholar
     

  • Tahir M, Arshid S, Fontes B, Castro MS, Luz IS, Botelho KLR, et al. Analysis of the effect of intestinal ischemia and reperfusion on the rat neutrophils proteome. Front Mol Biosci. 2018;5:1–15.

    Article 
    CAS 

    Google Scholar
     

  • Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA, and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021;11:13308.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zerbato V, di Bella S, Giuffre M, Jaracz AW, Gobbo Y, Luppino D, et al. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: a proof-of-concept study. World J Gastroenterol. 2021;27:3130–7.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69:1543–4.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F, et al. COVID-19 and intestinal inflammation: role of fecal calprotectin. Dig Liver Dis. 2020;52:1231–3.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Shokri-Afra H, Alikhani A, Moradipoodeh B, Noorbakhsh F, Fakheri H, Moradi-Sardareh H. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms. Sci Rep. 2021;11:22001.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Udeh R, Advani S, García L, Romualdo G, Dolja-Gore X. Calprotectin, an emerging biomarker of interest in COVID-19: a systematic review and meta-analysis. J Clin Med. 2021;10:775.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Burhan E, Dwi Susanto A, Isbaniah F, Aman Nasution S, Ginanjar E, Wicaksono Pitoyo C, et al. Pedoman Tatalaksana COVID-19 Edisi 3 Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif. 2020.

  • Sartini S, Massobrio L, Cutuli O, Campodonico P, Bernini C, Sartini M, et al. Role of SatO2, PaO2/FiO2 ratio and PaO2 to predict adverse outcome in COVID-19: a retrospective, cohort study. Int J Environ Res Public Health. 2021;18:11534.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest J. 2007;132:410–7.

    Article 

    Google Scholar
     

  • Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA J Am Med Assoc. 2012;307:2526–33.


    Google Scholar
     

  • Colgan SP, Campbell EL, Kominsky DJ. Hypoxia and mucosal inflammation. Annu Rev Pathol. 2016;11:77–100.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Singhal R, Shah YM. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J Biol Chem. 2020;295:10493–505.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95:1632–48.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Reisinger EC, Fritzsche C, Krause R, Krejs GJ. Diarrhea caused by primarily non-gastrointestinal infections. Nat Rev Gastroenterol Hepatol. 2005;2:216–22.

    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)